My Thoughts

Leveraging my experience as a co-founder of a biotechnology start-up, corporate development leader, and investor to discuss tactical and strategic considerations for building great biotech and pharma companies.

San Diego Life Science Funding Rebounds BIG in Q1 2024, But Will It Last?

Drew Hertig, MBA, CLP

Apr 103 min read

San Diego Life Science Funding Rebounds BIG in Q1 2024, But Will It Last?

Welcome back to biotech beach! Capital raised in Q1 2024 for San Diego-based life science companies jumped 324% from same period last...

47 views0 comments

5 Reasons Biotech Valuations Go Down When Inflation Goes Up (and what you can do about it)

Drew Hertig, MBA, CLP

Nov 26, 20238 min read

5 Reasons Biotech Valuations Go Down When Inflation Goes Up (and what you can do about it)

Unfortunately for biotechnology companies, their products have long development timelines and are perceived to be a high-risk investment....

99 views0 comments

Top Three Biotech Partnering Drivers for 2023

Drew Hertig, MBA, CLP

Jan 11, 20234 min read

Top Three Biotech Partnering Drivers for 2023

Biotech stocks have been beat up since February 2021, with the XBI index still down ~50% from record highs Headwinds in 2022 stemming...

7 views0 comments

Small Cap Biotech: When Will the 2021 Bear Market End?

Drew Hertig, MBA, CLP

Dec 31, 20216 min read

Small Cap Biotech: When Will the 2021 Bear Market End?

Negative sentiment in the biotech industry has driven the SPDR S&P Biotech ETF (XBI) down more than 30% from February highs....

38 views0 comments